The 4 analysts offering 12-month price forecasts for Calithera Biosciences Inc have a median target of 2.25, with a high estimate of 4.00 and a low estimate of 1.00. The median estimate represents a +184.81% increase from the last price of 0.79.
The current consensus among 5 polled investment analysts is to Hold stock in Calithera Biosciences Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.20
Reporting Date Mar 15
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.